Note by Dr Lane regarding discussions held with Dr Harvey and Dr Smith with extract from Minutes, covering hepatitis antigens in plasma and final products, and submissions for research and development projects and a paper headed Procedures for Reducing Hepatitis Risk in Plasma Products.